Laurie Long 11/14/07
There are currently six drugs available to slow the progression of MS (Avonex, Betaseron, Copaxone, Rebif, Novantrone and Tysabri). But whether you get it once a day or once a week, subcutaneous or intramuscular, you’re facing the needle over and over again. Effective oral drugs for MS have been a sought-after solution for a long time. Now, multiple drug companies are racing each other and the clock to get US Food and Drug Administration (FDA) approval for their particular offerings.
Most of the drugs below are currently in Phase III trials (the last trial phase before applying for FDA approval), which generally last 2-3 years. Time is also required to collate the data, apply to the FDA for new drug approval, and receive that approval. If it can meet the requirements, a drug can receive Priority Review, which speeds up the process of FDA review.
The big questions now are: what are these drugs, how do they work, how effective are they, what are their potential side effects and when will they gain FDA approval and hit the market? Let’s take a look…